CD44 and neoplasm: miR-34a was found to be underexpressed in several above-mentioned PCSC populations, especially the CD44+/hi PCa cells, and overexpression of miR-34a in bulk PCa cells or purified CD44+ cells elicited pronounced inhibitory effects on tumor growth and metastasis in vivo.